Breaking News Instant updates and real-time market news.

MO

Altria Group

$49.80

0.54 (1.10%)

, FOCS

Focus Financial Partners

$28.91

0.92 (3.29%)

10:14
07/12/19
07/12
10:14
07/12/19
10:14

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Buy from Neutral at Goldman Sachs with analyst Judy Hong saying the valuations in the tobacco sector are trading at a 10-year trough in spite of the "more accommodating" macro backdrop for Consumer Staples that includes a late cycle and lower yields. 2. Focus Financial (FOCS) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. Deutsche Bank (DB) upgraded to Neutral from Sell at UBS. 4. Morgan Stanley (MS) upgraded to Buy from Neutral at Citi. 5. Snap (SNAP) upgraded to Buy from Neutral at Goldman Sachs with analyst Heath Terry saying the company's new Android app, the launch of Snap Games, and new viral lenses should accelerator user growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MO

Altria Group

$49.80

0.54 (1.10%)

FOCS

Focus Financial Partners

$28.91

0.92 (3.29%)

DB

Deutsche Bank

$7.57

0.11 (1.47%)

MS

Morgan Stanley

$44.61

0.43 (0.97%)

SNAP

Snap

$15.74

0.17 (1.09%)

  • 18

    Jul

  • 18

    Jul

  • 23

    Jul

  • 24

    Jul

MO Altria Group
$49.80

0.54 (1.10%)

06/21/19
06/21/19
NO CHANGE

Former FDA head sees difficulty in JUUL getting PMTA approval, says Cowen
Cowen analyst Vivien Azer wrote in a note titled "Gottlieb: Out of FDA, Not Out of Opinions" that former FDA Commissioner Scott Gottlieb commented that he believes it will be difficult for JUUL to get PMTA approval, which has put vapor exposed stocks under pressure. Azer said that Altria (MO) has direct exposure as it has a 35% stake in JUUL, and Greenlane Holdings (GNLN) also has exposure as JUUL accounted for 36% of its sales in 2018. However, the analyst noted that JUUL is "already grand-fathered into the market today, given it was marketed prior to August 2016." Also, JUUL has been "among the most proactive participants in the market, having gone further than the FDA has contemplated in terms of addressing youth access." Azer has a Market Perform rating on Altria, and an Outperform rating on Greenlane.
07/11/19
GSCO
07/11/19
UPGRADE
GSCO
Buy
Altria Group upgraded to Buy from Neutral at Goldman Sachs
07/11/19
GSCO
07/11/19
UPGRADE
Target $59
GSCO
Buy
Altria Group upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Altria to Buy and kept her price target at $59, saying the valuations in the tobacco sector are trading at a 10-year trough in spite of the "more accommodating" macro backdrop for Consumer Staples that includes a late cycle and lower yields. The analyst believes that cigarette fundamentals will hold up "better than feared", regulatory concerns will subside, and companies will see a contribution from Next Generation tobacco products.
06/13/19
WELS
06/13/19
NO CHANGE
WELS
Outperform
Tobacco stocks to react favorably to Altria cigarette price increase, says Wells Fargo
Wells Fargo analyst Bonnie Lee Herzog says she just learned from her industry contacts that Altria Group/Philip Morris USA took a "surprise" cigarette list price increase that will be effective with shipments on or after June 16, several months earlier than Altria's typical practice of raising cigarette list prices every six months. Further, the analyst also learned from her retailer contacts that Altria has reduced certain promo allowances on some of its brands starting in July. Given the continued pressure on cigarette volumes, Herzog thinks this is a key reason Altria is being more aggressive with pricing in effort to offset volume declines/protect margins, and wouldn't be surprised if it took another increase in the fall or later this year. Overall, the analyst expects tobacco stocks will react favorably to this list price increase. She reiterates an Overweight rating on the tobacco sector and on Altria's stock.
FOCS Focus Financial Partners
$28.91

0.92 (3.29%)

07/12/19
KBWI
07/12/19
UPGRADE
Target $35.5
KBWI
Outperform
Focus Financial upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Kyle Voigt upgraded Focus Financial Partners to Outperform from Market Perform with an unchanged price target of $35.50.
06/27/19
RHCO
06/27/19
NO CHANGE
Target $30
RHCO
Hold
Focus Financial Partners price target lowered to $30 from $38 at SunTrust
SunTrust analyst Oscar Turner lowered his price target for Focus Financial Partners and maintained a Hold rating following a post-Q1 sell-off. Turner tells investors in a research note that he recently hosted meetings with the company's CEO and CFO, and management indicated that the deal pipeline remains strong, management will need to balance continued M&A with capital constraints, and Client Solutions could drive material long-term growth upside.
04/09/19
04/09/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. First Merchants (FRME) initiated with an Outperform at Raymond James. 2. Focus Financial Partners (FOCS) initiated with an Outperform at Oppenheimer. 3.FIS (FIS) initiated with an Outperform at Keefe Bruyette while Fiserv (FISV) was initiated with a Market Perform. 4. Fox Corp. (FOXA) initiated with a Neutral at Citi. 5. KLA-Tencor (KLAC) reinstated with a Sell at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/08/19
OPCO
04/08/19
INITIATION
Target $48
OPCO
Outperform
Focus Financial Partners initiated with an Outperform at Oppenheimer
Oppenheimer analyst Owen Lau started Focus Financial Partners with an Outperform rating and $48 price target. The company has an "attractive business model in a growing, highly fragmented but consolidating" registered investment advisory industry, Lau tells investors in a research note. The analyst believes an increasing number and assets of high net worth individuals along with the migration of brokers to advisors support a secular industry growth trend for Focus Financial. He thinks investors should use any weakness from the upcoming Q1 results as an entry point.
DB Deutsche Bank
$7.57

0.11 (1.47%)

05/20/19
05/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. American Airlines (AAL) downgraded to Underweight from Equal Weight at Morgan Stanley while Delta Air Lines (DAL) was downgraded to Equal Weight from Overweight. 2. Deutsche Bank (DB) downgraded to Sell from Neutral at UBS with the firm saying the bank is facing limited strategic options and its operating conditions are unlikely to improve in the near term amid intense competition. 3. Eaton Vance (EV) double downgraded to Underperform from Buy at BofA/Merrill with analyst Michael Carrier lowering estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. 4. ProAssurance (PRA) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Christopher Campbell saying the stock has rallied 9% since the company's "disappointing" Q1 results. 5. Clorox (CLX) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's revenue deceleration reported in Q3 to "just 2%" as well as its near-term growth outlook cut to 2%-3% from 2%-4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
BOFA
07/08/19
NO CHANGE
BOFA
Underperform
BofA keeps Underperform rating on Deutsche Bank, says capital still an issue
After Deutsche Bank released its outline of its new plan to improve profitability, BofA Merrill Lynch analyst Andrew Stimpson said the cost ambitions are greater than he expected, but he believes capital will continue to be an issue as the bank decided to not raise equity. Also, preliminary Q2 underlying results missed consensus, noted Stimpson, who keeps an Underperform rating on Deutsche Bank shares with many details of the company's plan still outstanding.
07/12/19
UBSW
07/12/19
UPGRADE
UBSW
Neutral
Deutsche Bank upgraded to Neutral from Sell at UBS
UBS upgraded Deutsche Bank to Neutral from Sell following the recent selloff in the shares.
07/08/19
RBCM
07/08/19
NO CHANGE
RBCM
Underperform
Deutsche Bank business review 'more radical than expected', says RBC Capital
RBC Capital analyst Anke Reingen raised her price target on Deutsche Bank to EUR8 from EUR7.50, saying its transformation plan announced over the weekend is "more radical than expected" and could support its shares over the short term. The analyst maintained her Underperform rating however, noting that the bank's execution will be key, while also pointing to the company's pushed out projections for improvement in profitability.
MS Morgan Stanley
$44.61

0.43 (0.97%)

04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/24/19
UBSW
06/24/19
NO CHANGE
UBSW
DFAST results encourgaing for Wells Fargo, says UBS
UBS analyst Saul Martinez said the DFAST results from the Federal Reserve, reported after the close on Friday, were most encouraging for "those who didn't fare as well last year," like Wells Fargo (WFC). He thinks Goldman Sachs (GS), Morgan Stanley (MS) and State Street (STT) look like they have room to reach his forecasted capital returns and also said lower stressed losses at Citi (C) and JPMorgan (JPM) could suggest that the current SCB proposal may not lead to materially higher minimum capital requirements, added Martinez. However, he thinks there could be some downside to his capital return estimates for Capital One (COF), which he notes have been above consensus.
07/12/19
SBSH
07/12/19
UPGRADE
SBSH
Buy
Morgan Stanley upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Morgan Stanley to Buy from Neutral.
07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.
SNAP Snap
$15.74

0.17 (1.09%)

07/12/19
GSCO
07/12/19
UPGRADE
Target $18
GSCO
Buy
Snap upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Heath Terry upgraded Snap to Buy from Neutral and raised his price target for the shares to $18 from $13. The stock closed Thursday up 31c to $15.57. The company's new Android app, the launch of Snap Games and new viral lenses should accelerator user growth, Terry tells investors in a research note. He points out that Snap's total app downloads for May, the first month reflecting these recent innovations, was a record 41M. This represents a "stark reversal" of what were otherwise multi-year lows in app downloads that the platform experienced through most of 2018 and early 2019, says the analyst.
07/11/19
BOFA
07/11/19
NO CHANGE
Target $17
BOFA
Neutral
Snap price target raised to $17 from $12 at BofA/Merrill
BofA/Merrill analyst Justin Post raised his price target for Snap to $17 from $12 ahead of the company's Q2 results while keeping a Neutral rating on the name. Snap's "gender-face-swap" filter went viral in May and its SnapKit app "Yolo" reached number one on the iOS download charts, Post tells investors in a pre-earnings research note. Further, third party Snap app data in Q2 suggests downloads were near record levels, adds the analyst. However, for advertisers, channel checks remains mixed, says Post. The analyst expects improving user trends and revenue upside in Q2, but he thinks Snap will remain conservative in its outlook.
07/09/19
FBCO
07/09/19
NO CHANGE
Target $18
FBCO
Outperform
Snap price target raised to $18 from $15 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Snap to $18 from $15 while keeping an Overweight rating on the shares. The stock closed Monday down 9c to $15.14. The analyst calculates that the number of Snap ads per session remains at ~0.3. Even if 80% of the sessions are spent on chat versus the Discover page, this still implies that Snap is showing less than two ads per session on average, Ju tells investors in a research note. This suggests there remains "significant room" for the company to increase the ad load in pursuit of revenue growth, contends the analyst.
07/01/19
MOFT
07/01/19
NO CHANGE
Target $10
MOFT
Neutral
MoffettNathanson sees 'massive' upside DAU surprise at Snap, ups target to $10
MoffettNathanson analyst Michael Nathanson raised his price target on Snap to $10 from $8 as he increased his 2020 revenue estimate by 9% to account for projecting stronger user growth due to "impressive trends" from the Snapchat Ads manager. While Nathanson said he believes that "Snap is on the verge of writing their own 'Cinderella Story' due to the likelihood of a massive upside surprise in DAU growth" in Q2 and raised his 2019 total DAU estimate by 21M to 223M, he keeps a Neutral rating on the stock, citing valuation and concerns that the market is overestimating operating leverage.

TODAY'S FREE FLY STORIES

CSX

CSX

$71.17

-8.4 (-10.56%)

, UNP

Union Pacific

$164.98

-10.12 (-5.78%)

13:01
07/17/19
07/17
13:01
07/17/19
13:01
Downgrade
CSX, Union Pacific, Kansas City Southern, Norfolk Southern rating change  »

Cascend downgrades four…

CSX

CSX

$71.17

-8.4 (-10.56%)

UNP

Union Pacific

$164.98

-10.12 (-5.78%)

KSU

Kansas City Southern

$117.42

-5.41 (-4.40%)

NSC

Norfolk Southern

$193.18

-13.35 (-6.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

  • 24

    Jul

  • 26

    Aug

  • 13

    Nov

UPS

UPS

$103.54

-2.07 (-1.96%)

12:55
07/17/19
07/17
12:55
07/17/19
12:55
Options
UPS put volume heavy and directionally bearish »

Bearish flow noted in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

VAR

Varian Medical

$134.22

-0.72 (-0.53%)

, VRAY

ViewRay

$9.31

0.16 (1.75%)

12:49
07/17/19
07/17
12:49
07/17/19
12:49
Recommendations
Varian Medical, ViewRay analyst commentary  »

Competitor recall…

VAR

Varian Medical

$134.22

-0.72 (-0.53%)

VRAY

ViewRay

$9.31

0.16 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Sep

TTWO

Take-Two

$118.37

0.88 (0.75%)

12:43
07/17/19
07/17
12:43
07/17/19
12:43
Earnings
Stephens, Cowen up Take-Two price targets ahead of Q1 results »

Take-Two (TTWO) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 05

    Aug

  • 05

    Sep

  • 13

    Nov

SSRM

SSR Mining

$14.72

0.665 (4.73%)

12:25
07/17/19
07/17
12:25
07/17/19
12:25
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
07/17/19
07/17
12:25
07/17/19
12:25
General news
Treasury Action: the downdraft in European rates has helped pulling Treasury yields lower »

Treasury Action: the…

CAPR

Capricor Therapeutics

$6.39

0.48 (8.12%)

12:25
07/17/19
07/17
12:25
07/17/19
12:25
Conference/Events
Capricor Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

IBM

IBM

$142.94

-0.6 (-0.42%)

12:24
07/17/19
07/17
12:24
07/17/19
12:24
Earnings
Fly Intel: What to watch in IBM's earnings report »

IBM (IBM) is scheduled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

AMZN

Amazon.com

$1,999.39

-10.61 (-0.53%)

, QCOM

Qualcomm

$76.74

1.08 (1.43%)

12:23
07/17/19
07/17
12:23
07/17/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have dropped in…

AMZN

Amazon.com

$1,999.39

-10.61 (-0.53%)

QCOM

Qualcomm

$76.74

1.08 (1.43%)

MSFT

Microsoft

$137.11

0.03 (0.02%)

T

AT&T

$33.47

-0.1 (-0.30%)

BAC

Bank of America

$29.47

0.475 (1.64%)

CSX

CSX

$71.11

-8.46 (-10.63%)

ABT

Abbott

$86.33

3.22 (3.87%)

SGEN

Seattle Genetics

$73.43

10.31 (16.33%)

INO

Inovio

$2.65

-0.35 (-11.67%)

NUS

Nu Skin

$37.95

-7.55 (-16.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 26

    Aug

  • 06

    Sep

  • 09

    Sep

  • 13

    Nov

KSU

Kansas City Southern

$118.05

-4.78 (-3.89%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

NSC

Norfolk Southern

$194.90

-11.63 (-5.63%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Norfolk Southern rating change  »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Aug

CSX

CSX

$71.21

-8.36 (-10.51%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
CSX rating change  »

CSX downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

UNP

Union Pacific

$166.50

-8.6 (-4.91%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Downgrade
Union Pacific rating change at C.K. Cooper »

Union Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/17/19
07/17
12:16
07/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$59.31

0.36 (0.61%)

12:15
07/17/19
07/17
12:15
07/17/19
12:15
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
07/17/19
07/17
12:15
07/17/19
12:15
General news
Breaking General news story  »

Kansas City Federal…

CBB

Cincinnati Bell

$4.28

-0.44 (-9.32%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Cincinnati Bell falls -9.5% »

Cincinnati Bell is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$21.02

-2.08 (-9.00%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -9.0% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$38.13

-7.37 (-16.20%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Nu Skin falls -16.0% »

Nu Skin is down -16.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

AG

First Majestic

$9.10

0.53 (6.18%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
First Majestic rises 6.2% »

First Majestic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$70.17

5.71 (8.86%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 8.7% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.55

0.37 (11.65%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Fortuna Silver Mines rises 11.6% »

Fortuna Silver Mines is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
07/17/19
07/17
11:55
07/17/19
11:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

11:55
07/17/19
07/17
11:55
07/17/19
11:55
Conference/Events
Federal Reserve Bank of Kansas City to speak on economic outlook »

Kansas City Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.